Contrast-inDuced nephRotoxicity as Assessed by the KIdney Load-to-DAmage RElationship
NCT01908309 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2015-06-23
Summary
We previously demonstrated that the slope of the relationship plotting individual iodine loads against contrast-induced serum creatinine changes ( the load-to-damage relationship, LDR) characterizes the intrinsic nephrotoxicity of the contrast. Aim of the present study is to compare, through the assessment of the LDR slope, the intrinsic nephrotoxicity of two different contrast media using serum cystatin-C changes as the LDR dependent variable.
Conditions
- Contrast Induced Acute Kidney Injury
Interventions
- DRUG
-
Iobitridol 350
- DRUG
-
Iodixanol 320
Sponsors & Collaborators
-
Azienda Sanitaria Locale 9, Grosseto
lead OTHER_GOV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-04-30
- Primary Completion
- 2014-10-31
- Completion
- 2014-10-31
Countries
- Italy
Study Locations
More Related Trials
-
Iodixanol vs. Iomeprol to Prevent Contrast-Induced Nephropathy After Coronary Intervention (CONTRAST)
NCT00390585 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Contrast Induced Nephropathy (NIC) by Intravenous Versus Oral Rehydration
NCT00908843 ·Status: COMPLETED ·Phase: NA
-
The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy
NCT03627130 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Two Iodinated Contrast Agents in Renally Impaired Patients Undergoing Cardiac Angiography
NCT00289029 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy
NCT01093131 ·Status: WITHDRAWN ·Phase: PHASE4
-
Contrast Agent-associated Nephrotoxicity in Intensive Care Unit Patients
NCT01017796 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Sodium Chloride and Contrast Nephropathy
NCT03476460 ·Status: COMPLETED ·Phase: PHASE2
-
Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease
NCT04163484 ·Status: COMPLETED
-
Balanced Salt Solution Versus 0.9% Saline Infusion for Prevention of Contrast-induced Acute Kidney Injury (BASIC Trial)
NCT02799368 ·Status: COMPLETED ·Phase: PHASE3
-
Biochemical Effects of Remote Ischemic Pre-Conditioning on Contrast-induced Acute Kidney Injury
NCT03236441 ·Status: COMPLETED ·Phase: NA
-
Ioxaglate Versus Iodixanol for the Prevention of Contrast-induced Nephropathy in High-risk Patients (IDPC Trial)
NCT02991742 ·Status: UNKNOWN
-
Comparative Study of the Efficacy of Oral Versus Intravenous Hydration as a Preventive Measure of Contrast-induced Nephropathy (CIN) in Patients With Renal Insufficiency (RI) Grade III Under Study Conducting Computed Tomography (CT)
NCT02872155 ·Status: COMPLETED ·Phase: PHASE3
-
Patients With Renal Impairment and Diabetes Undergoing Computed Tomography (CT)
NCT00289614 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction
NCT01160627 ·Status: COMPLETED ·Phase: NA
-
N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients
NCT00780962 ·Status: COMPLETED ·Phase: PHASE2
-
Risk of Acute Kidney Injury After Intravenous Contrast Computed Tomography Scans
NCT04606056 ·Status: ACTIVE_NOT_RECRUITING
-
A Maastricht Contrast-Induced Nephropathy Guidelines Study: CIN Prevention Guidelines: Appropriate & Cost-effective?
NCT02106234 ·Status: COMPLETED ·Phase: NA
-
Red Blood Cell Distribution Width as a Marker of Contrast Induced Nephropathy in Patients With Coronary Intervention
NCT03164681 ·Status: UNKNOWN
-
Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic Patients
NCT00782639 ·Status: TERMINATED ·Phase: PHASE4
-
Short-Term Alpha Lipoic Acid Therapy for Prevention of Contrast-induced Acute Kidney Injury and Endothelial Dysfunction in Type 2 Diabetes
NCT01978405 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Intravenous Acetadote on Incidence of Contrast Induced Nephropathy
NCT00939913 ·Status: UNKNOWN ·Phase: PHASE4
-
Effectiveness of Remote Ischemic Preconditioning for Prevention of Contrast Induced Acute Kidney Injury in Patients Undergoing Coronary Angiograms.
NCT05147831 ·Status: RECRUITING ·Phase: NA
-
Intravenous High Dose NAC and Sodium Bicarbonate for the Prevention of Contrast-induced Acute Injury
NCT01612013 ·Status: COMPLETED ·Phase: NA
-
PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION
NCT00130598 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy Trial of N-Acetylcysteine and Sodium Bicarbonate for the Prevention of Contrast-Induced Acute Kidney Injury
NCT01210456 ·Status: UNKNOWN ·Phase: PHASE3